Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Citeline is the world’s most comprehensive provider of real-time R&D intelligence to the pharmaceutical industry, featuring an unmatched data collection of global clinical trials, vetted investigators and trial sites and drug development pipelines.
Our data is curated by the industry’s largest team of expert analysts, making Citeline the most trusted source of R&D intelligence on the market.
With over 30,000 users, our data supports strategic decisions across the lifecycle of drug development, informing both commercial and clinical strategies. Our analysts work with clients to support clinical planning activities including protocol design, country feasibility, enrollment benchmarking and site identification and selection, while our trial engagement solutions enhance your efforts to raise trial awareness, educate HCPs and patients, and accelerate trial enrollment.
Download our whitepaper to find out how the COVID-19 pandemic impacted clinical trial development during 2020
The clinical trial landscape continues to evolve as scientific breakthroughs and technological innovations emerge. Find out more in our annual whitepaper.
Trialtrove’s trial timing insight provides actual enrollment and treatment benchmarks to support your financial, operational and commercial planning. Learn more in this free download.
Trialtrove enables you to reinforce your strategic position, clinically and commercially with industry-leading clinical trial insight to position your asset for success. Learn more in this free download.
Download our Use Case to see how Sitetrove can help locate investigators experienced in studies with adjuvant therapy in non-small cell lung cancer (NSCLC)
Penned for the 29th time by Ian Lloyd – Senior Director, Pharmaprojects, the Pharma R&D Annual Review 2021 is ready to transport you into the pharma R&D universe.
This year’s supplement provides detailed statistics, year-on-year trends and insightful analysis on the year’s NAS launches, making this a must-read for the pharma industry.
Using the new, granular datapoints in Pharmaprojects, Senior Director Ian Lloyd presents his expert insights into pharma’s R&D activities over the past year.
Ian Lloyd – Senior Director, Pharmaprojects, shares his expert insights on the new drugs approved for use in patients that made it to market during the year.
Tap into expert analysis of the trends and what they mean for the future of pharma with Citeline’s whitepaper
We have received your request and we will get back to you soon.
